THANK YOU FOR SUBSCRIBING
EphyX Neuroscience possesses an outstanding capability to test the effects on neuronal electrical activity and potential defensive mechanisms of various compounds, from single cells to network of cells and tissues. "We can provide a clear and detailed picture of the effects of various compounds on neuronal physiology, from brain circuits to single ion channels. Additionally, by capturing data from human cells at preclinical stages, clients can optimise the selection of compounds to limit the risk of failures drastically," explains Lalanne.![]()
Our perfect blend with an innovative on-site platform that offers key in vivo data, coupled with our in vitro specialization unique opportunity for pharmaceutical firms to boost their neuroscience-related preclinical research
Share this Article:
Tweet
|
Company
EphyX Neuroscience
Headquarters
Bordeaux, Nouvelle-Aquitaine
Management
Txomin Lalanne, President, and Co-Founder
Description
EphyX Neuroscience is a CRO specialized in in vitro (acute slices) electrophysiology applied to the early CNS-related preclinical phases and drug discovery. The company aims to quickly and efficiently help its clients optimize their compound selection to limit the risk of failure. With highly qualified experts performing recordings in acute slices from both rodent and human, makes EphyX Neuroscience’s data truely predictive. Additionally, EphyX propose both pre-designed packages tackling key aspects of selected conditions and on-demand services to address client-specific needs and assess mechanistic details of their compound's action. We partner with an innovative in vivo platform on site, providing key complementary in vivo data which, together with our in vitro specialization, offers a rare oportunity to boost CNS pre-clinical drug discovery